| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Chief Accounting Officer | Common Stock | 132K | $8.78M | $66.39 | Nov 16, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Nov 16, 2025 | 1 | -$317K | 4 | Nov 18, 2025 | Chief Accounting Officer |
| BBIO | BridgeBio Pharma, Inc. | Aug 16, 2025 | 1 | -$245K | 4 | Aug 19, 2025 | Chief Accounting Officer |
| BBIO | BridgeBio Pharma, Inc. | Aug 7, 2025 | 1 | -$45.4K | 4 | Aug 11, 2025 | Chief Accounting Officer |
| BBIO | BridgeBio Pharma, Inc. | May 16, 2025 | 1 | -$162K | 4 | May 20, 2025 | Chief Accounting Officer |
| BBIO | BridgeBio Pharma, Inc. | May 2, 2025 | 1 | -$39.5K | 4 | May 6, 2025 | Chief Accounting Officer |
| BBIO | BridgeBio Pharma, Inc. | Mar 19, 2025 | 1 | $0 | 4 | Mar 21, 2025 | Chief Accounting Officer |
| BBIO | BridgeBio Pharma, Inc. | Feb 19, 2025 | 0 | $0 | 3 | Feb 27, 2025 | Chief Accounting Officer |